Alcorn Harry W Jr - Net Worth and Insider Trading
Alcorn Harry W Jr Net Worth
The estimated net worth of Alcorn Harry W Jr is at least $183,621 dollars as of 2024-11-08. Alcorn Harry W Jr is the SVP, Clinical Operations of DiaMedica Therapeutics Inc and owns about 43,981 shares of DiaMedica Therapeutics Inc (DMAC) stock worth over $183,621. Details can be seen in Alcorn Harry W Jr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alcorn Harry W Jr has not made any transactions after 2021-09-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alcorn Harry W Jr
Alcorn Harry W Jr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alcorn Harry W Jr owns 1 companies in total, including DiaMedica Therapeutics Inc (DMAC) .
Click here to see the complete history of Alcorn Harry W Jr’s form 4 insider trades.
Insider Ownership Summary of Alcorn Harry W Jr
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DMAC | DiaMedica Therapeutics Inc | 2021-09-15 | Chief Medical Officer |
Alcorn Harry W Jr Latest Holdings Summary
Alcorn Harry W Jr currently owns a total of 1 stock. Alcorn Harry W Jr owns 43,981 shares of DiaMedica Therapeutics Inc (DMAC) as of September 15, 2021, with a value of $183,621.
Latest Holdings of Alcorn Harry W Jr
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DMAC | DiaMedica Therapeutics Inc | 2021-09-15 | 43,981 | 4.18 | 183,621 |
Holding Weightings of Alcorn Harry W Jr
Alcorn Harry W Jr Form 4 Trading Tracker
According to the SEC Form 4 filings, Alcorn Harry W Jr has made a total of 2 transactions in DiaMedica Therapeutics Inc (DMAC) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in DiaMedica Therapeutics Inc is the acquisition of 15,000 shares on September 15, 2021, which cost Alcorn Harry W Jr around $57,000.
Insider Trading History of Alcorn Harry W Jr
- 1
Alcorn Harry W Jr Trading Performance
GuruFocus tracks the stock performance after each of Alcorn Harry W Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alcorn Harry W Jr is 11.84%. GuruFocus also compares Alcorn Harry W Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alcorn Harry W Jr within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alcorn Harry W Jr's insider trading performs compared to the benchmark.
Performance of Alcorn Harry W Jr
Alcorn Harry W Jr Ownership Network
Ownership Network List of Alcorn Harry W Jr
Ownership Network Relation of Alcorn Harry W Jr
Alcorn Harry W Jr Owned Company Details
What does DiaMedica Therapeutics Inc do?
Who are the key executives at DiaMedica Therapeutics Inc?
Alcorn Harry W Jr is the Chief Medical Officer of DiaMedica Therapeutics Inc. Other key executives at DiaMedica Therapeutics Inc include 10 percent owner Koch Thomas Von , 10 percent owner Jan Stahlberg , and CFO and Secretary Scott Kellen .
DiaMedica Therapeutics Inc (DMAC) Insider Trades Summary
Over the past 18 months, Alcorn Harry W Jr made no insider transaction in DiaMedica Therapeutics Inc (DMAC). Other recent insider transactions involving DiaMedica Therapeutics Inc (DMAC) include a net purchase of 2,670,588 shares made by Koch Thomas Von , a net purchase of 58,364 shares made by David J. Wambeke , and a net purchase of 1,200,000 shares made by Jan Stahlberg .
In summary, during the past 3 months, insiders sold 0 shares of DiaMedica Therapeutics Inc (DMAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DiaMedica Therapeutics Inc (DMAC) were sold and 4,067,889 shares were bought by its insiders, resulting in a net purchase of 4,067,889 shares.
DiaMedica Therapeutics Inc (DMAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
DiaMedica Therapeutics Inc Insider Transactions
Alcorn Harry W Jr Mailing Address
Above is the net worth, insider trading, and ownership report for Alcorn Harry W Jr. You might contact Alcorn Harry W Jr via mailing address: 2 Carlson Parkway, Suite 260, Minneapolis Mn 55447.